News
leading to capacity degradation. To mitigate this issue, we propose a novel closed-loop OAM system featuring adaptive phase-shift control for transmission signals. We also introduce efficient methods ...
To solve these issues, this article incorporates switched-controlled capacitors (SCC) into the LCC-S topology to perform adaptive tracking for zero-phase-angle (ZPA) and maximum output voltage across ...
The company's leading candidate recently reported positive ... Notably, Verve Therapeutics recently announced positive results from a Phase 1b clinical trial for VERVE-102 as a potential treatment ...
Hosted on MSN18d
MPS lead exposure; next phase of cleanup, action plan announcedMPS and the City Health Commissioner on Monday will announce the next phase of lead cleanup and the lead action plan. Mark Carney Wins Canadian Election Dominated By Trump The Obamas’ Old ...
Caribou's two lead Phase 1 clinical programs, CB-010 for large B cell lymphoma and CB-011 for multiple myeloma, continue to demonstrate encouraging efficacy and have the potential to serve this ...
Caribou’s two lead Phase 1 clinical programs, CB-010 for large B cell lymphoma and CB-011 for multiple myeloma, continue to demonstrate encouraging efficacy and have the potential to serve this ...
“I’m excited to join Jerry and the team to lead the next stage of growth, empowering more organisations to harness AI and activate transformative change. We will wield AI as the sharp tip of the ...
One of its candidates was called lotiglipron, an investigational oral GLP-1 pill it discontinued after phase 1 studies due to its potentially causing liver problems. The company's leading program ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results